MedPath

MK-2637

Generic Name
MK-2637

Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)

Phase 1
Completed
Conditions
Schizophrenia
Interventions
First Posted Date
2009-07-08
Last Posted Date
2015-06-24
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
15
Registration Number
NCT00934466
© Copyright 2025. All Rights Reserved by MedPath